

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | establishment of mitochondrion localization (GO:0051654) | 5.71222080 |
| 2 | behavioral response to nicotine (GO:0035095) | 5.57444281 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.45065329 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 5.20256852 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.16207870 |
| 6 | neuron cell-cell adhesion (GO:0007158) | 5.05073743 |
| 7 | synaptic vesicle maturation (GO:0016188) | 5.01135954 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.98228460 |
| 9 | vocalization behavior (GO:0071625) | 4.96299591 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.77583051 |
| 11 | protein localization to synapse (GO:0035418) | 4.69750109 |
| 12 | glutamate secretion (GO:0014047) | 4.46174066 |
| 13 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.45404640 |
| 14 | regulation of synaptic vesicle transport (GO:1902803) | 4.39238183 |
| 15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.35154598 |
| 16 | mitochondrion transport along microtubule (GO:0047497) | 4.30146260 |
| 17 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 4.30146260 |
| 18 | locomotory exploration behavior (GO:0035641) | 4.27205945 |
| 19 | neurofilament cytoskeleton organization (GO:0060052) | 4.24764919 |
| 20 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.18007779 |
| 21 | neurotransmitter secretion (GO:0007269) | 4.11735107 |
| 22 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.99846428 |
| 23 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.97697870 |
| 24 | layer formation in cerebral cortex (GO:0021819) | 3.97374286 |
| 25 | neuron recognition (GO:0008038) | 3.96594956 |
| 26 | cell migration in hindbrain (GO:0021535) | 3.94418783 |
| 27 | neuronal action potential propagation (GO:0019227) | 3.93382240 |
| 28 | exploration behavior (GO:0035640) | 3.90736099 |
| 29 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.80916128 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 3.79543061 |
| 31 | response to pheromone (GO:0019236) | 3.71034899 |
| 32 | negative regulation of microtubule polymerization (GO:0031115) | 3.71031814 |
| 33 | postsynaptic membrane organization (GO:0001941) | 3.70948622 |
| 34 | regulation of synapse structural plasticity (GO:0051823) | 3.70395603 |
| 35 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.69585758 |
| 36 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.65998478 |
| 37 | axonal fasciculation (GO:0007413) | 3.65402068 |
| 38 | glutamate receptor signaling pathway (GO:0007215) | 3.63755808 |
| 39 | neuron-neuron synaptic transmission (GO:0007270) | 3.62533967 |
| 40 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.58389453 |
| 41 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.58389453 |
| 42 | dendritic spine morphogenesis (GO:0060997) | 3.57514401 |
| 43 | positive regulation of synapse maturation (GO:0090129) | 3.53765487 |
| 44 | proline transport (GO:0015824) | 3.50976069 |
| 45 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.47367828 |
| 46 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.43470585 |
| 47 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.38719891 |
| 48 | regulation of vesicle fusion (GO:0031338) | 3.37647369 |
| 49 | dendrite morphogenesis (GO:0048813) | 3.37284438 |
| 50 | regulation of neurotransmitter secretion (GO:0046928) | 3.34794403 |
| 51 | neurotransmitter transport (GO:0006836) | 3.33813146 |
| 52 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.31817772 |
| 53 | axon extension (GO:0048675) | 3.31047463 |
| 54 | synapse assembly (GO:0007416) | 3.30837662 |
| 55 | synaptic vesicle endocytosis (GO:0048488) | 3.30172064 |
| 56 | presynaptic membrane assembly (GO:0097105) | 3.29253011 |
| 57 | nucleobase catabolic process (GO:0046113) | 3.28294920 |
| 58 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.27688183 |
| 59 | positive regulation of membrane potential (GO:0045838) | 3.25232064 |
| 60 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.24292479 |
| 61 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.22821385 |
| 62 | innervation (GO:0060384) | 3.22310861 |
| 63 | forebrain neuron differentiation (GO:0021879) | 3.19340718 |
| 64 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.19072522 |
| 65 | synaptic transmission, cholinergic (GO:0007271) | 3.18813856 |
| 66 | presynaptic membrane organization (GO:0097090) | 3.18716388 |
| 67 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.18029993 |
| 68 | neuronal ion channel clustering (GO:0045161) | 3.17501773 |
| 69 | regulation of postsynaptic membrane potential (GO:0060078) | 3.16237661 |
| 70 | retinal ganglion cell axon guidance (GO:0031290) | 3.13450845 |
| 71 | transmission of nerve impulse (GO:0019226) | 3.12971720 |
| 72 | long-term memory (GO:0007616) | 3.10238881 |
| 73 | positive regulation of synapse assembly (GO:0051965) | 3.09747300 |
| 74 | activation of protein kinase A activity (GO:0034199) | 3.09059693 |
| 75 | gamma-aminobutyric acid transport (GO:0015812) | 3.08301699 |
| 76 | regulation of neurotransmitter transport (GO:0051588) | 3.04877830 |
| 77 | mechanosensory behavior (GO:0007638) | 3.02720465 |
| 78 | long-term synaptic potentiation (GO:0060291) | 3.02494472 |
| 79 | regulation of neurotransmitter levels (GO:0001505) | 3.02370522 |
| 80 | sequestering of actin monomers (GO:0042989) | 3.01033641 |
| 81 | auditory behavior (GO:0031223) | 3.00127004 |
| 82 | membrane depolarization during action potential (GO:0086010) | 2.99202306 |
| 83 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.98697954 |
| 84 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.98343653 |
| 85 | regulation of synaptic plasticity (GO:0048167) | 2.98013736 |
| 86 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.96720271 |
| 87 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.96714826 |
| 88 | adult walking behavior (GO:0007628) | 2.94109176 |
| 89 | detection of calcium ion (GO:0005513) | 2.93660146 |
| 90 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.93494423 |
| 91 | establishment of synaptic vesicle localization (GO:0097480) | 2.93436912 |
| 92 | synaptic vesicle transport (GO:0048489) | 2.93436912 |
| 93 | regulation of respiratory system process (GO:0044065) | 2.93223382 |
| 94 | spinal cord association neuron differentiation (GO:0021527) | 2.91855245 |
| 95 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.91285504 |
| 96 | membrane hyperpolarization (GO:0060081) | 2.91006731 |
| 97 | membrane depolarization (GO:0051899) | 2.90433556 |
| 98 | cerebellum development (GO:0021549) | 2.90058774 |
| 99 | mating behavior (GO:0007617) | 2.88427575 |
| 100 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.88290301 |
| 101 | hippocampus development (GO:0021766) | 2.88279434 |
| 102 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.87953553 |
| 103 | response to auditory stimulus (GO:0010996) | 2.87634223 |
| 104 | neuromuscular process controlling posture (GO:0050884) | 2.87295666 |
| 105 | neuromuscular synaptic transmission (GO:0007274) | 2.86265073 |
| 106 | spinal cord development (GO:0021510) | 2.85625047 |
| 107 | regulation of feeding behavior (GO:0060259) | 2.84951581 |
| 108 | regulation of synapse maturation (GO:0090128) | 2.84778647 |
| 109 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.83856370 |
| 110 | synapse organization (GO:0050808) | 2.83659754 |
| 111 | regulation of synapse assembly (GO:0051963) | 2.82796457 |
| 112 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.82727072 |
| 113 | establishment of vesicle localization (GO:0051650) | 2.82145195 |
| 114 | neuron projection extension (GO:1990138) | 2.81984558 |
| 115 | cerebellar Purkinje cell layer development (GO:0021680) | 2.81579116 |
| 116 | synaptic transmission (GO:0007268) | 2.81015676 |
| 117 | protein localization to cilium (GO:0061512) | 2.80698483 |
| 118 | glycosphingolipid biosynthetic process (GO:0006688) | 2.80545706 |
| 119 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.80229261 |
| 120 | learning (GO:0007612) | 2.79940522 |
| 121 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.79595721 |
| 122 | dendrite development (GO:0016358) | 2.79583275 |
| 123 | cell communication by electrical coupling (GO:0010644) | 2.77733362 |
| 124 | intraspecies interaction between organisms (GO:0051703) | 2.77455466 |
| 125 | social behavior (GO:0035176) | 2.77455466 |
| 126 | cerebellar granule cell differentiation (GO:0021707) | 2.77335369 |
| 127 | negative regulation of axonogenesis (GO:0050771) | 2.75980376 |
| 128 | nonmotile primary cilium assembly (GO:0035058) | 2.72334190 |
| 129 | nervous system development (GO:0007399) | 2.72207847 |
| 130 | positive regulation of mitochondrial fission (GO:0090141) | 2.72022381 |
| 131 | cell differentiation in hindbrain (GO:0021533) | 2.71532011 |
| 132 | negative regulation of axon extension (GO:0030517) | 2.68780061 |
| 133 | limb bud formation (GO:0060174) | 2.68347800 |
| 134 | regulation of action potential (GO:0098900) | 2.65409515 |
| 135 | neuron migration (GO:0001764) | 2.64724842 |
| 136 | behavioral defense response (GO:0002209) | 2.63401915 |
| 137 | behavioral fear response (GO:0001662) | 2.63401915 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.51790533 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.62310549 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.22467326 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.08277935 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.03208310 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.98672297 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.90680179 |
| 8 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.79561294 |
| 9 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.77115123 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.76724402 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.62818040 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.62818040 |
| 13 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.55130113 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.51293049 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.50343049 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.48484170 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.47876412 |
| 18 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.45177615 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.43340845 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.40382960 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.34090768 |
| 22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.33698312 |
| 23 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.24159383 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.20059386 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.18865674 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.12055461 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.10364571 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.96273458 |
| 29 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.92559613 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.91687213 |
| 31 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.87000602 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.73165301 |
| 33 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.72682423 |
| 34 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.69683033 |
| 35 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.62498868 |
| 36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.62238177 |
| 37 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.61631406 |
| 38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.61398159 |
| 39 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.59960673 |
| 40 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.57900540 |
| 41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.57870982 |
| 42 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.55158093 |
| 43 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.52689602 |
| 44 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.51482115 |
| 45 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.49214115 |
| 46 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.46024899 |
| 47 | P300_19829295_ChIP-Seq_ESCs_Human | 1.38702196 |
| 48 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.38247743 |
| 49 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.37392070 |
| 50 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.35941804 |
| 51 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.35724086 |
| 52 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.32823648 |
| 53 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32009215 |
| 54 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28885943 |
| 55 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24847184 |
| 56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22667699 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.21415293 |
| 58 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.19104173 |
| 59 | FUS_26573619_Chip-Seq_HEK293_Human | 1.18943344 |
| 60 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.18763991 |
| 61 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.17493973 |
| 62 | VDR_22108803_ChIP-Seq_LS180_Human | 1.16624413 |
| 63 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.15926636 |
| 64 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13108741 |
| 65 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.11281841 |
| 66 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.10766389 |
| 67 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.10080178 |
| 68 | STAT3_23295773_ChIP-Seq_U87_Human | 1.10059995 |
| 69 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.09407649 |
| 70 | AR_19668381_ChIP-Seq_PC3_Human | 1.09269052 |
| 71 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.08172785 |
| 72 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07853847 |
| 73 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.07237098 |
| 74 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06511331 |
| 75 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06172974 |
| 76 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05111738 |
| 77 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.03561422 |
| 78 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.03175628 |
| 79 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02077561 |
| 80 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.99746082 |
| 81 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99633495 |
| 82 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.99412098 |
| 83 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98921478 |
| 84 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98867971 |
| 85 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97884387 |
| 86 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97659116 |
| 87 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.96988162 |
| 88 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.96803892 |
| 89 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.96760179 |
| 90 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.94636444 |
| 91 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94636444 |
| 92 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.93710094 |
| 93 | TCF4_23295773_ChIP-Seq_U87_Human | 0.93285392 |
| 94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91250338 |
| 95 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90193808 |
| 96 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.89963397 |
| 97 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.89963397 |
| 98 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.89719833 |
| 99 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89493508 |
| 100 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89409604 |
| 101 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.88621355 |
| 102 | JUN_21703547_ChIP-Seq_K562_Human | 0.88314201 |
| 103 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.88133422 |
| 104 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.87613777 |
| 105 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.87579275 |
| 106 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.86399154 |
| 107 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85955372 |
| 108 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.85927262 |
| 109 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.85093762 |
| 110 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.84647323 |
| 111 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.84628801 |
| 112 | KDM2B_26808549_Chip-Seq_K562_Human | 0.84415183 |
| 113 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.84135805 |
| 114 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.83706978 |
| 115 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.82901314 |
| 116 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.82662093 |
| 117 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.82275387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.90326696 |
| 2 | MP0003880_abnormal_central_pattern | 3.93846640 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.55364523 |
| 4 | MP0004270_analgesia | 3.54572145 |
| 5 | MP0002063_abnormal_learning/memory/cond | 2.95281903 |
| 6 | MP0001968_abnormal_touch/_nociception | 2.86123138 |
| 7 | MP0005423_abnormal_somatic_nervous | 2.85148683 |
| 8 | MP0006276_abnormal_autonomic_nervous | 2.83500454 |
| 9 | MP0009745_abnormal_behavioral_response | 2.78876602 |
| 10 | MP0002734_abnormal_mechanical_nocicepti | 2.77224538 |
| 11 | MP0002064_seizures | 2.63505787 |
| 12 | MP0009046_muscle_twitch | 2.55027554 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.53429487 |
| 14 | MP0005645_abnormal_hypothalamus_physiol | 2.48260459 |
| 15 | MP0002735_abnormal_chemical_nociception | 2.47847878 |
| 16 | MP0002184_abnormal_innervation | 2.33592143 |
| 17 | MP0002272_abnormal_nervous_system | 2.31672224 |
| 18 | MP0002736_abnormal_nociception_after | 2.30708370 |
| 19 | MP0002733_abnormal_thermal_nociception | 2.28470283 |
| 20 | MP0000778_abnormal_nervous_system | 2.22500277 |
| 21 | MP0001486_abnormal_startle_reflex | 2.17075132 |
| 22 | MP0003122_maternal_imprinting | 2.06733161 |
| 23 | MP0001970_abnormal_pain_threshold | 2.04870132 |
| 24 | MP0001984_abnormal_olfaction | 2.00607006 |
| 25 | MP0001440_abnormal_grooming_behavior | 1.94360923 |
| 26 | MP0002067_abnormal_sensory_capabilities | 1.93318787 |
| 27 | MP0002557_abnormal_social/conspecific_i | 1.92448550 |
| 28 | MP0002822_catalepsy | 1.91547227 |
| 29 | MP0002909_abnormal_adrenal_gland | 1.85274389 |
| 30 | MP0004811_abnormal_neuron_physiology | 1.83710198 |
| 31 | MP0004858_abnormal_nervous_system | 1.81740832 |
| 32 | MP0010386_abnormal_urinary_bladder | 1.81220172 |
| 33 | MP0001501_abnormal_sleep_pattern | 1.75311388 |
| 34 | MP0003787_abnormal_imprinting | 1.75128905 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.73371152 |
| 36 | MP0003123_paternal_imprinting | 1.70862559 |
| 37 | MP0000955_abnormal_spinal_cord | 1.70180488 |
| 38 | MP0005394_taste/olfaction_phenotype | 1.69153875 |
| 39 | MP0005499_abnormal_olfactory_system | 1.69153875 |
| 40 | MP0002638_abnormal_pupillary_reflex | 1.68006636 |
| 41 | MP0001529_abnormal_vocalization | 1.65938280 |
| 42 | MP0009780_abnormal_chondrocyte_physiolo | 1.62885013 |
| 43 | MP0005386_behavior/neurological_phenoty | 1.62372333 |
| 44 | MP0004924_abnormal_behavior | 1.62372333 |
| 45 | MP0002882_abnormal_neuron_morphology | 1.56019506 |
| 46 | MP0008569_lethality_at_weaning | 1.49967416 |
| 47 | MP0001502_abnormal_circadian_rhythm | 1.49402741 |
| 48 | MP0008877_abnormal_DNA_methylation | 1.44143781 |
| 49 | MP0001905_abnormal_dopamine_level | 1.39993202 |
| 50 | MP0001188_hyperpigmentation | 1.39840991 |
| 51 | MP0008789_abnormal_olfactory_epithelium | 1.39180675 |
| 52 | MP0003329_amyloid_beta_deposits | 1.38611884 |
| 53 | MP0004142_abnormal_muscle_tone | 1.37764359 |
| 54 | MP0003879_abnormal_hair_cell | 1.36684235 |
| 55 | MP0002066_abnormal_motor_capabilities/c | 1.34208678 |
| 56 | MP0003890_abnormal_embryonic-extraembry | 1.31020880 |
| 57 | MP0004133_heterotaxia | 1.29662338 |
| 58 | MP0000631_abnormal_neuroendocrine_gland | 1.23987118 |
| 59 | MP0002751_abnormal_autonomic_nervous | 1.20517008 |
| 60 | MP0002152_abnormal_brain_morphology | 1.19968925 |
| 61 | MP0008995_early_reproductive_senescence | 1.18888542 |
| 62 | MP0006292_abnormal_olfactory_placode | 1.15923715 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.13903619 |
| 64 | MP0004885_abnormal_endolymph | 1.13765887 |
| 65 | MP0006072_abnormal_retinal_apoptosis | 1.12487565 |
| 66 | MP0000049_abnormal_middle_ear | 1.10105713 |
| 67 | MP0000013_abnormal_adipose_tissue | 1.07875524 |
| 68 | MP0005551_abnormal_eye_electrophysiolog | 1.07386193 |
| 69 | MP0002752_abnormal_somatic_nervous | 1.05229153 |
| 70 | MP0002653_abnormal_ependyma_morphology | 1.04829799 |
| 71 | MP0002069_abnormal_eating/drinking_beha | 1.02023638 |
| 72 | MP0002837_dystrophic_cardiac_calcinosis | 1.01900127 |
| 73 | MP0002229_neurodegeneration | 0.99220155 |
| 74 | MP0008961_abnormal_basal_metabolism | 0.98229372 |
| 75 | MP0003011_delayed_dark_adaptation | 0.97517871 |
| 76 | MP0004742_abnormal_vestibular_system | 0.97070091 |
| 77 | MP0000569_abnormal_digit_pigmentation | 0.96365791 |
| 78 | MP0001986_abnormal_taste_sensitivity | 0.91958259 |
| 79 | MP0003633_abnormal_nervous_system | 0.91395426 |
| 80 | MP0003121_genomic_imprinting | 0.90774798 |
| 81 | MP0003938_abnormal_ear_development | 0.90711540 |
| 82 | MP0002876_abnormal_thyroid_physiology | 0.87243858 |
| 83 | MP0003283_abnormal_digestive_organ | 0.87110327 |
| 84 | MP0001963_abnormal_hearing_physiology | 0.86052988 |
| 85 | MP0000751_myopathy | 0.84612155 |
| 86 | MP0003861_abnormal_nervous_system | 0.83862493 |
| 87 | MP0005195_abnormal_posterior_eye | 0.82028535 |
| 88 | MP0003631_nervous_system_phenotype | 0.80422707 |
| 89 | MP0003634_abnormal_glial_cell | 0.80185107 |
| 90 | MP0004145_abnormal_muscle_electrophysio | 0.77701442 |
| 91 | MP0004085_abnormal_heartbeat | 0.77647471 |
| 92 | MP0003119_abnormal_digestive_system | 0.75148861 |
| 93 | MP0004043_abnormal_pH_regulation | 0.73176224 |
| 94 | MP0005535_abnormal_body_temperature | 0.73132557 |
| 95 | MP0005253_abnormal_eye_physiology | 0.73041328 |
| 96 | MP0002938_white_spotting | 0.72128583 |
| 97 | MP0002928_abnormal_bile_duct | 0.72065799 |
| 98 | MP0004130_abnormal_muscle_cell | 0.71920846 |
| 99 | MP0000566_synostosis | 0.71622400 |
| 100 | MP0000026_abnormal_inner_ear | 0.70618596 |
| 101 | MP0001485_abnormal_pinna_reflex | 0.69658341 |
| 102 | MP0002160_abnormal_reproductive_system | 0.69083225 |
| 103 | MP0001664_abnormal_digestion | 0.68606540 |
| 104 | MP0005084_abnormal_gallbladder_morpholo | 0.68069279 |
| 105 | MP0005187_abnormal_penis_morphology | 0.67487822 |
| 106 | MP0003137_abnormal_impulse_conducting | 0.66616668 |
| 107 | MP0001299_abnormal_eye_distance/ | 0.66599853 |
| 108 | MP0004147_increased_porphyrin_level | 0.66005278 |
| 109 | MP0002081_perinatal_lethality | 0.65490002 |
| 110 | MP0008872_abnormal_physiological_respon | 0.64644682 |
| 111 | MP0003136_yellow_coat_color | 0.64640303 |
| 112 | MP0009379_abnormal_foot_pigmentation | 0.64469739 |
| 113 | MP0002234_abnormal_pharynx_morphology | 0.64439998 |
| 114 | MP0000538_abnormal_urinary_bladder | 0.63544265 |
| 115 | MP0002102_abnormal_ear_morphology | 0.61110959 |
| 116 | MP0001944_abnormal_pancreas_morphology | 0.59221460 |
| 117 | MP0001943_abnormal_respiration | 0.58425495 |
| 118 | MP0002082_postnatal_lethality | 0.56059857 |
| 119 | MP0010770_preweaning_lethality | 0.56059857 |
| 120 | MP0002693_abnormal_pancreas_physiology | 0.55832107 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.61359895 |
| 2 | Myokymia (HP:0002411) | 5.58043401 |
| 3 | Focal seizures (HP:0007359) | 4.65320903 |
| 4 | Visual hallucinations (HP:0002367) | 4.55532290 |
| 5 | Atonic seizures (HP:0010819) | 4.49975171 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.18451770 |
| 7 | Febrile seizures (HP:0002373) | 4.13272992 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 3.86419442 |
| 9 | Absence seizures (HP:0002121) | 3.76141619 |
| 10 | Limb dystonia (HP:0002451) | 3.51909109 |
| 11 | Dialeptic seizures (HP:0011146) | 3.32180485 |
| 12 | Amblyopia (HP:0000646) | 3.26775805 |
| 13 | Failure to thrive in infancy (HP:0001531) | 3.21187319 |
| 14 | Pachygyria (HP:0001302) | 3.16343751 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 3.15591203 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 3.14846935 |
| 17 | Cortical dysplasia (HP:0002539) | 3.14031214 |
| 18 | Ankle clonus (HP:0011448) | 3.12378395 |
| 19 | Pheochromocytoma (HP:0002666) | 3.05968023 |
| 20 | Polyphagia (HP:0002591) | 3.04940923 |
| 21 | Agitation (HP:0000713) | 3.02337087 |
| 22 | Action tremor (HP:0002345) | 2.97696248 |
| 23 | Abnormal eating behavior (HP:0100738) | 2.91984140 |
| 24 | Broad-based gait (HP:0002136) | 2.88509592 |
| 25 | Epileptiform EEG discharges (HP:0011182) | 2.86642998 |
| 26 | Hepatoblastoma (HP:0002884) | 2.86566524 |
| 27 | EEG with generalized epileptiform discharges (HP:0011198) | 2.83039055 |
| 28 | Gait imbalance (HP:0002141) | 2.82598707 |
| 29 | Truncal ataxia (HP:0002078) | 2.79936993 |
| 30 | Depression (HP:0000716) | 2.74772366 |
| 31 | Hyperventilation (HP:0002883) | 2.71990807 |
| 32 | Hypsarrhythmia (HP:0002521) | 2.71334926 |
| 33 | Anxiety (HP:0000739) | 2.67899029 |
| 34 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.62878625 |
| 35 | Drooling (HP:0002307) | 2.62399387 |
| 36 | Excessive salivation (HP:0003781) | 2.62399387 |
| 37 | Neuroendocrine neoplasm (HP:0100634) | 2.62357643 |
| 38 | Poor eye contact (HP:0000817) | 2.53068508 |
| 39 | Nephronophthisis (HP:0000090) | 2.52455759 |
| 40 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.51362686 |
| 41 | Abnormality of midbrain morphology (HP:0002418) | 2.49698038 |
| 42 | Molar tooth sign on MRI (HP:0002419) | 2.49698038 |
| 43 | Spastic tetraplegia (HP:0002510) | 2.49370847 |
| 44 | Mutism (HP:0002300) | 2.48686097 |
| 45 | Abnormal hair whorl (HP:0010721) | 2.47289930 |
| 46 | Progressive inability to walk (HP:0002505) | 2.47113736 |
| 47 | Hemiparesis (HP:0001269) | 2.37132793 |
| 48 | Specific learning disability (HP:0001328) | 2.35093224 |
| 49 | Spastic gait (HP:0002064) | 2.33862566 |
| 50 | Hypothermia (HP:0002045) | 2.33752368 |
| 51 | Hypoventilation (HP:0002791) | 2.31288110 |
| 52 | Pancreatic fibrosis (HP:0100732) | 2.30651207 |
| 53 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.30053826 |
| 54 | Congenital primary aphakia (HP:0007707) | 2.28822931 |
| 55 | True hermaphroditism (HP:0010459) | 2.27520856 |
| 56 | Gaze-evoked nystagmus (HP:0000640) | 2.26411915 |
| 57 | Medial flaring of the eyebrow (HP:0010747) | 2.25294339 |
| 58 | Papilledema (HP:0001085) | 2.24788930 |
| 59 | Abnormal social behavior (HP:0012433) | 2.23623345 |
| 60 | Impaired social interactions (HP:0000735) | 2.23623345 |
| 61 | Abnormality of the lower motor neuron (HP:0002366) | 2.23070523 |
| 62 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.21461491 |
| 63 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.21461491 |
| 64 | Type II lissencephaly (HP:0007260) | 2.20530687 |
| 65 | Hypoplasia of the brainstem (HP:0002365) | 2.20486855 |
| 66 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.20486855 |
| 67 | Pancreatic cysts (HP:0001737) | 2.19713756 |
| 68 | Dysdiadochokinesis (HP:0002075) | 2.19677158 |
| 69 | Nephrogenic diabetes insipidus (HP:0009806) | 2.18958269 |
| 70 | Poor suck (HP:0002033) | 2.18805453 |
| 71 | Genetic anticipation (HP:0003743) | 2.18525425 |
| 72 | Pendular nystagmus (HP:0012043) | 2.16911827 |
| 73 | Urinary urgency (HP:0000012) | 2.16314401 |
| 74 | Abnormality of the corticospinal tract (HP:0002492) | 2.14090929 |
| 75 | Hypoplasia of the corpus callosum (HP:0002079) | 2.13720299 |
| 76 | Insidious onset (HP:0003587) | 2.13537938 |
| 77 | Termporal pattern (HP:0011008) | 2.13537938 |
| 78 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.10502966 |
| 79 | Esotropia (HP:0000565) | 2.09886870 |
| 80 | Poor coordination (HP:0002370) | 2.08781268 |
| 81 | Dysmetria (HP:0001310) | 2.06613663 |
| 82 | Torticollis (HP:0000473) | 2.05893422 |
| 83 | Absent speech (HP:0001344) | 2.05741421 |
| 84 | Impaired smooth pursuit (HP:0007772) | 2.05172402 |
| 85 | Amyotrophic lateral sclerosis (HP:0007354) | 2.04623010 |
| 86 | Lissencephaly (HP:0001339) | 2.04085137 |
| 87 | Hyperthyroidism (HP:0000836) | 2.03830863 |
| 88 | Sleep apnea (HP:0010535) | 2.02836748 |
| 89 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.02267508 |
| 90 | Stereotypic behavior (HP:0000733) | 2.00533740 |
| 91 | Megalencephaly (HP:0001355) | 2.00472893 |
| 92 | Focal dystonia (HP:0004373) | 2.00395516 |
| 93 | Abnormality of the labia minora (HP:0012880) | 1.97040962 |
| 94 | Protruding tongue (HP:0010808) | 1.96616625 |
| 95 | Chronic hepatic failure (HP:0100626) | 1.96412353 |
| 96 | Scanning speech (HP:0002168) | 1.96138524 |
| 97 | Narrow forehead (HP:0000341) | 1.95566827 |
| 98 | Genital tract atresia (HP:0001827) | 1.95321158 |
| 99 | Lower limb muscle weakness (HP:0007340) | 1.94958259 |
| 100 | Vaginal atresia (HP:0000148) | 1.94873146 |
| 101 | Fetal akinesia sequence (HP:0001989) | 1.94455976 |
| 102 | Anosmia (HP:0000458) | 1.93912843 |
| 103 | Status epilepticus (HP:0002133) | 1.93764162 |
| 104 | Exotropia (HP:0000577) | 1.92768381 |
| 105 | Inability to walk (HP:0002540) | 1.90120078 |
| 106 | Hip dysplasia (HP:0001385) | 1.90067266 |
| 107 | Labial hypoplasia (HP:0000066) | 1.89262963 |
| 108 | Oligomenorrhea (HP:0000876) | 1.88998191 |
| 109 | Retinal dysplasia (HP:0007973) | 1.88681736 |
| 110 | Bradykinesia (HP:0002067) | 1.87530160 |
| 111 | Abnormality of the renal medulla (HP:0100957) | 1.86608204 |
| 112 | Polymicrogyria (HP:0002126) | 1.86490072 |
| 113 | Anencephaly (HP:0002323) | 1.86170757 |
| 114 | Peripheral hypomyelination (HP:0007182) | 1.85704414 |
| 115 | Neurofibrillary tangles (HP:0002185) | 1.85040966 |
| 116 | Shoulder girdle muscle weakness (HP:0003547) | 1.84378444 |
| 117 | Shawl scrotum (HP:0000049) | 1.83417089 |
| 118 | Cerebral inclusion bodies (HP:0100314) | 1.82259267 |
| 119 | Thyroid-stimulating hormone excess (HP:0002925) | 1.81945162 |
| 120 | Abnormality of alanine metabolism (HP:0010916) | 1.81921215 |
| 121 | Hyperalaninemia (HP:0003348) | 1.81921215 |
| 122 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.81921215 |
| 123 | Abnormality of pain sensation (HP:0010832) | 1.80844551 |
| 124 | Impaired pain sensation (HP:0007328) | 1.80844551 |
| 125 | Insomnia (HP:0100785) | 1.80803233 |
| 126 | Congenital stationary night blindness (HP:0007642) | 1.80057368 |
| 127 | Psychosis (HP:0000709) | 1.79977407 |
| 128 | Growth hormone deficiency (HP:0000824) | 1.79599907 |
| 129 | Muscular hypotonia of the trunk (HP:0008936) | 1.78779293 |
| 130 | Craniofacial dystonia (HP:0012179) | 1.78660724 |
| 131 | Narrow nasal bridge (HP:0000446) | 1.78624939 |
| 132 | Optic nerve hypoplasia (HP:0000609) | 1.78426487 |
| 133 | Abnormality of salivation (HP:0100755) | 1.78251162 |
| 134 | Abnormality of binocular vision (HP:0011514) | 1.75793305 |
| 135 | Diplopia (HP:0000651) | 1.75793305 |
| 136 | Akinesia (HP:0002304) | 1.75624718 |
| 137 | Intellectual disability, severe (HP:0010864) | 1.75243666 |
| 138 | Acute necrotizing encephalopathy (HP:0006965) | 1.74592510 |
| 139 | Oligodactyly (hands) (HP:0001180) | 1.74414844 |
| 140 | Anomalous pulmonary venous return (HP:0010772) | 1.72950940 |
| 141 | Decreased muscle mass (HP:0003199) | 1.72839749 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.51206764 |
| 2 | NTRK3 | 3.78211960 |
| 3 | MAP3K9 | 3.23230774 |
| 4 | MINK1 | 2.92189767 |
| 5 | MAP3K4 | 2.91401369 |
| 6 | MAP2K7 | 2.65980094 |
| 7 | CASK | 2.63345290 |
| 8 | NTRK2 | 2.36022765 |
| 9 | MAP3K12 | 2.28577072 |
| 10 | MAP4K2 | 2.26303209 |
| 11 | EPHA4 | 2.24818440 |
| 12 | SIK3 | 2.15766938 |
| 13 | MAPK13 | 2.09405268 |
| 14 | PINK1 | 2.07368274 |
| 15 | KSR1 | 2.03901197 |
| 16 | DAPK2 | 1.89988789 |
| 17 | PAK6 | 1.83766302 |
| 18 | UHMK1 | 1.79338307 |
| 19 | MAP2K4 | 1.72953609 |
| 20 | INSRR | 1.62687450 |
| 21 | SIK2 | 1.59420952 |
| 22 | GRK5 | 1.57539853 |
| 23 | ARAF | 1.56858057 |
| 24 | PLK2 | 1.51029419 |
| 25 | BCR | 1.47728751 |
| 26 | CDK5 | 1.47252152 |
| 27 | DYRK2 | 1.46483736 |
| 28 | NTRK1 | 1.46105242 |
| 29 | EPHB2 | 1.44730902 |
| 30 | KSR2 | 1.41323370 |
| 31 | PNCK | 1.38420594 |
| 32 | PRKD3 | 1.35925523 |
| 33 | STK16 | 1.35249314 |
| 34 | DAPK1 | 1.33642078 |
| 35 | DYRK1B | 1.30186805 |
| 36 | SGK223 | 1.26340889 |
| 37 | SGK494 | 1.26340889 |
| 38 | PHKG2 | 1.26261597 |
| 39 | PHKG1 | 1.26261597 |
| 40 | ERBB3 | 1.21649353 |
| 41 | CDK19 | 1.21110291 |
| 42 | DYRK3 | 1.20956603 |
| 43 | EPHA3 | 1.20664654 |
| 44 | PRKCG | 1.20270909 |
| 45 | TNIK | 1.16837774 |
| 46 | TRIM28 | 1.14949614 |
| 47 | WNK3 | 1.14610290 |
| 48 | LIMK1 | 1.13823762 |
| 49 | DYRK1A | 1.06719991 |
| 50 | AKT3 | 1.06184178 |
| 51 | CAMKK1 | 1.06067841 |
| 52 | BRAF | 1.06009572 |
| 53 | MAPK15 | 1.02462993 |
| 54 | SGK2 | 1.00238754 |
| 55 | MAP3K2 | 1.00197090 |
| 56 | CDK18 | 0.97640546 |
| 57 | CSNK1G2 | 0.96515479 |
| 58 | PRPF4B | 0.95850018 |
| 59 | NME1 | 0.94818471 |
| 60 | CDK14 | 0.91769903 |
| 61 | CAMKK2 | 0.90886750 |
| 62 | CAMK2A | 0.90257524 |
| 63 | ADRBK2 | 0.89856846 |
| 64 | PAK3 | 0.85484447 |
| 65 | CAMK2B | 0.85427907 |
| 66 | CSNK1G1 | 0.84943391 |
| 67 | CDK15 | 0.84651261 |
| 68 | MARK2 | 0.82654107 |
| 69 | CDK11A | 0.74413149 |
| 70 | RPS6KA2 | 0.73917810 |
| 71 | CAMK1D | 0.70529159 |
| 72 | RET | 0.68863348 |
| 73 | FRK | 0.68245429 |
| 74 | PRKCE | 0.68113350 |
| 75 | TYRO3 | 0.66183875 |
| 76 | BCKDK | 0.64444362 |
| 77 | LATS2 | 0.64155677 |
| 78 | PRKCZ | 0.63427797 |
| 79 | GRK1 | 0.62227361 |
| 80 | BMPR1B | 0.60116351 |
| 81 | CAMK1G | 0.59465540 |
| 82 | CSNK1G3 | 0.58781111 |
| 83 | STK11 | 0.57767109 |
| 84 | SGK3 | 0.56411822 |
| 85 | RIPK4 | 0.56269806 |
| 86 | FER | 0.56036473 |
| 87 | CAMK1 | 0.55083826 |
| 88 | FES | 0.54898887 |
| 89 | BMPR2 | 0.54043369 |
| 90 | CCNB1 | 0.53747547 |
| 91 | PRKCH | 0.53620843 |
| 92 | CSNK1A1 | 0.53390337 |
| 93 | CAMK2D | 0.51455392 |
| 94 | OXSR1 | 0.49187780 |
| 95 | CDC42BPA | 0.48931252 |
| 96 | PRKAA1 | 0.48840942 |
| 97 | SGK1 | 0.48419200 |
| 98 | ADRBK1 | 0.47590314 |
| 99 | STK38 | 0.47436418 |
| 100 | MAP3K6 | 0.46251782 |
| 101 | CAMK2G | 0.43875960 |
| 102 | CSNK1D | 0.42955813 |
| 103 | HIPK2 | 0.42749390 |
| 104 | MAP2K1 | 0.42655127 |
| 105 | ERBB2 | 0.42417758 |
| 106 | CAMK4 | 0.40647071 |
| 107 | WNK4 | 0.40612145 |
| 108 | PRKCI | 0.38296115 |
| 109 | RPS6KA3 | 0.37344939 |
| 110 | MAPKAPK5 | 0.37053812 |
| 111 | MAPK10 | 0.34221301 |
| 112 | MAPK9 | 0.33161944 |
| 113 | PRKACA | 0.33119680 |
| 114 | PRKCB | 0.32909615 |
| 115 | LMTK2 | 0.32647245 |
| 116 | CSNK1A1L | 0.32491454 |
| 117 | PKN1 | 0.32408067 |
| 118 | RAF1 | 0.31628473 |
| 119 | MAPK8 | 0.30792855 |
| 120 | MAP3K1 | 0.30111615 |
| 121 | IRAK2 | 0.30098628 |
| 122 | CSNK1E | 0.29849530 |
| 123 | PRKG1 | 0.29550329 |
| 124 | PTK2B | 0.29459472 |
| 125 | PRKACB | 0.29061511 |
| 126 | PRKCA | 0.27347083 |
| 127 | GSK3B | 0.27294882 |
| 128 | FYN | 0.26755855 |
| 129 | PRKDC | 0.24065546 |
| 130 | PRKACG | 0.23669749 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.81148762 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.66473981 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.72324013 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.63058184 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.62731809 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.53751874 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.39771270 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.36953857 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.33156311 |
| 10 | Insulin secretion_Homo sapiens_hsa04911 | 2.33145298 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.31610220 |
| 12 | Long-term potentiation_Homo sapiens_hsa04720 | 2.30136250 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.24655043 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.20525068 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 2.15385733 |
| 16 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.11273658 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.96118460 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.92104209 |
| 19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.89093288 |
| 20 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.70316619 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 1.65431230 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.58222445 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.56007114 |
| 24 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.55906487 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.47044277 |
| 26 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.43656111 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.39684789 |
| 28 | Axon guidance_Homo sapiens_hsa04360 | 1.39676995 |
| 29 | Gap junction_Homo sapiens_hsa04540 | 1.35338638 |
| 30 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.34500765 |
| 31 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.29029707 |
| 32 | Phototransduction_Homo sapiens_hsa04744 | 1.25786351 |
| 33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.25283573 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.24305593 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.24275538 |
| 36 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.19551035 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.18806126 |
| 38 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.15552790 |
| 39 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.04032472 |
| 40 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.02853692 |
| 41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.02482786 |
| 42 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.01969000 |
| 43 | Parkinsons disease_Homo sapiens_hsa05012 | 1.01358846 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 1.01019895 |
| 45 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.00554664 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98160444 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.97553146 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.96892191 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.96665100 |
| 50 | Melanogenesis_Homo sapiens_hsa04916 | 0.96609464 |
| 51 | Protein export_Homo sapiens_hsa03060 | 0.96120689 |
| 52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.95937097 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94439300 |
| 54 | Glioma_Homo sapiens_hsa05214 | 0.92679709 |
| 55 | Alcoholism_Homo sapiens_hsa05034 | 0.88032325 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.86198930 |
| 57 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.85170117 |
| 58 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83876845 |
| 59 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.76533015 |
| 60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.75038202 |
| 61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.74183359 |
| 62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.73624851 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73370515 |
| 64 | Huntingtons disease_Homo sapiens_hsa05016 | 0.73009574 |
| 65 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.71689171 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71155905 |
| 67 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.69307356 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.69090256 |
| 69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68281014 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67706048 |
| 71 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66450951 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65437721 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65315715 |
| 74 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.64712250 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64049802 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61308347 |
| 77 | Basal transcription factors_Homo sapiens_hsa03022 | 0.61028077 |
| 78 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.60176467 |
| 79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59940671 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59121440 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56379290 |
| 82 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55895791 |
| 83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55835745 |
| 84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54517435 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53839146 |
| 86 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53779712 |
| 87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53543816 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.53464437 |
| 89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52773568 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51342950 |
| 91 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49942815 |
| 92 | Sulfur relay system_Homo sapiens_hsa04122 | 0.49346911 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48905177 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48788984 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47971311 |
| 96 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.47825491 |
| 97 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.47579884 |
| 98 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.47041861 |
| 99 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46284867 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.45897026 |
| 101 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44151046 |
| 102 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43602616 |
| 103 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.43400044 |
| 104 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.42672191 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42377324 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42172006 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41025007 |
| 108 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.40894784 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40635081 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40240740 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.40014523 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.39598991 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37842671 |
| 114 | Peroxisome_Homo sapiens_hsa04146 | 0.37814723 |
| 115 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.37798408 |
| 116 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.35452213 |
| 117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34646680 |
| 118 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34548302 |
| 119 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.33478153 |
| 120 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33415660 |
| 121 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.32685154 |
| 122 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.32631262 |
| 123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31317983 |
| 124 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30637617 |
| 125 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.26518958 |
| 126 | Bile secretion_Homo sapiens_hsa04976 | 0.23593582 |
| 127 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.22765189 |
| 128 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.22016927 |
| 129 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.21694632 |
| 130 | Metabolic pathways_Homo sapiens_hsa01100 | 0.20254462 |
| 131 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.20238577 |

